Contact Now
Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shaanxi Kaishi Biotechnology Co., Ltd
Product Description
Methotrexate 98% is a high-quality pharmaceutical active pharmaceutical ingredient (API) widely used in oncology, autoimmune disorder treatment, and advanced pharmaceutical formulation development. It belongs to the antimetabolite class and plays a critical role in chemotherapy and immunosuppressive drug production.
As global demand continues to expand for Pharmaceutical Enzymes, Nutritional Ingredients, and advanced Standardized Extracts, Methotrexate remains a key compound in regulated pharmaceutical manufacturing and CDMO supply chains.
Content Note: Prepared by our technical team based on peer-reviewed scientific literature. All content is intended for industrial and research use only and complies with FDA/EFSA communication guidelines. Last reviewed: June 2026
According to a study in The New England Journal of Medicine (1989), methotrexate demonstrated significant efficacy in the treatment of rheumatoid arthritis, supporting its long-term use as a disease-modifying agent.
According to a study in Journal of Clinical Oncology (2002), methotrexate-based chemotherapy regimens showed measurable therapeutic outcomes in certain types of lymphoma and solid tumors.
Methotrexate 98% is manufactured under strict GMP-controlled environments to ensure consistent purity, stability, and pharmaceutical compliance for global markets.
| Parameter | Specification |
|---|---|
| Active Ingredient | Methotrexate |
| Purity | ≥ 98% |
| Appearance | Yellow to orange crystalline powder |
| Test Method | HPLC |
| Form | API powder / injectable intermediate |
| Storage | 2–8°C, dry and light-protected |
The quality of Methotrexate 98% is determined by synthesis route, purification technology, and strict quality assurance systems. Pharmaceutical-grade production ensures safety and consistency across batches.
| Production Stage | Impact on Quality |
|---|---|
| Chemical synthesis process | Ensures structural consistency and potency |
| Multi-stage purification | Reduces impurities and improves safety profile |
| Controlled drying process | Enhances stability and shelf life |
| API | Mechanism | Application |
|---|---|---|
| Methotrexate | Folate pathway inhibition | Cancer, rheumatoid arthritis, autoimmune diseases |
| Docetaxel | Microtubule stabilization | Solid tumor chemotherapy |
| Cyclophosphamide | DNA alkylation | Broad oncology applications |
Methotrexate 98% is widely used in pharmaceutical manufacturing and clinical drug development for both oncology and immunology indications.
It is also used in broader research contexts involving Plant Extracts , Antioxidants , Vitamins, and Nutritional Ingredients in pharmaceutical innovation and formulation science.
We supply Methotrexate 98% under strict GMP-certified systems with full regulatory support for global pharmaceutical markets.
It is used as an active pharmaceutical ingredient in cancer treatment and autoimmune disease therapies.
Yes, it is commonly formulated into sterile injectable dosage forms under GMP conditions.
The standard purity is ≥98%, verified through HPLC testing methods.
It should be stored at 2–8°C in a dry, light-protected environment to maintain stability.
Yes, we support OEM, private label, and contract manufacturing services for global clients.
Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.